Euglycemic diabetic ketoacidosis associated with sodium-glucose cotransporter-2 inhibitor use: a case report and review of the literature

BACKGROUND: The sodium-glucose cotransporter-2 (SGLT2) inhibitors are the newest class of anti-hyperglycemic medications used in the treatment of diabetes mellitus. Their increasing use has been driven by their apparent cardiovascular and renal benefits. They have been associated with a small but si...

Descripción completa

Detalles Bibliográficos
Autores principales: Diaz-Ramos, Alexis, Eilbert, Wesley, Marquez, Diego
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2019
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6727509/
https://www.ncbi.nlm.nih.gov/pubmed/31488052
http://dx.doi.org/10.1186/s12245-019-0240-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6727509/
https://www.ncbi.nlm.nih.gov/pubmed/31488052
http://dx.doi.org/10.1186/s12245-019-0240-0

Ejemplares similares